Enlivex Therapeutics Ltd. (ENLV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 32.14M |
| Enterprise Value | 30.77M |
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.61 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | 0.84 |
| Return On Equity | 2.11 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -332,000 |
| EBITDA | -14.67M |
| Net Income | 1.24B |
| Diluted EPS | 6,115.2 |
Balance Sheet
| Total Cash | 5.52M |
| Total Cash/Share | 5.34 |
| Total Debt | 17.25M |
| Total Debt/Equity | 0 |
| Current Ratio | 119.39 |
| Book Value Per Share | 3,770.78 |
Price History
| 52-Week Change | -99.51 |
| 52-Week High | 434.4 |
| 52-Week Low | 1.18 |
| Moving Average 50 Days | 7.13 |
| Moving Average 200 Days | 129.38 |
Statistics
| Average Volume | 70,607 |
| Shares Outstanding | 16.83M |
| % Held by Institutions | 9.35 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | October 27, 2026 |
AD
